- Home
- NRDS vs BBNX Comparison
NRDS vs BBNX Comparison
Compare NRDS & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRDS
- BBNX
- Stock Information
- Founded
- NRDS 2009
- BBNX 2015
- Country
- NRDS United States
- BBNX United States
- Employees
- NRDS N/A
- BBNX N/A
- Industry
- NRDS EDP Services
- BBNX Medical/Dental Instruments
- Sector
- NRDS Technology
- BBNX Health Care
- Exchange
- NRDS Nasdaq
- BBNX Nasdaq
- Market Cap
- NRDS 810.0M
- BBNX 649.9M
- IPO Year
- NRDS 2021
- BBNX 2025
- Fundamental
- Price
- NRDS $10.59
- BBNX $12.67
- Analyst Decision
- NRDS Buy
- BBNX Strong Buy
- Analyst Count
- NRDS 6
- BBNX 10
- Target Price
- NRDS $15.17
- BBNX $25.20
- AVG Volume (30 Days)
- NRDS 417.1K
- BBNX 476.5K
- Earning Date
- NRDS 07-30-2025
- BBNX 07-29-2025
- Dividend Yield
- NRDS N/A
- BBNX N/A
- EPS Growth
- NRDS N/A
- BBNX N/A
- EPS
- NRDS 0.38
- BBNX N/A
- Revenue
- NRDS $734,900,000.00
- BBNX $69,830,000.00
- Revenue This Year
- NRDS $18.07
- BBNX $32.79
- Revenue Next Year
- NRDS $8.22
- BBNX $36.59
- P/E Ratio
- NRDS $28.05
- BBNX N/A
- Revenue Growth
- NRDS 24.20
- BBNX 38911.17
- 52 Week Low
- NRDS $7.55
- BBNX $8.89
- 52 Week High
- NRDS $16.45
- BBNX $24.50
- Technical
- Relative Strength Index (RSI)
- NRDS 42.52
- BBNX N/A
- Support Level
- NRDS $11.07
- BBNX N/A
- Resistance Level
- NRDS $11.49
- BBNX N/A
- Average True Range (ATR)
- NRDS 0.32
- BBNX 0.00
- MACD
- NRDS -0.04
- BBNX 0.00
- Stochastic Oscillator
- NRDS 13.19
- BBNX 0.00
About NRDS NerdWallet Inc.
Nerdwallet Inc is a company that provides consumer-driven advice about personal finance through its platform by connecting individuals and small and mid-sized businesses (SMBs) with providers of financial products. It gets revenue from fees paid by its financial services partners in the form of either revenue per action, revenue per click, revenue per lead and revenue per funded loan arrangements.
About BBNX Beta Bionics Inc. Common Stock
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.